Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Mid-range Performer
1774.9000 6.00 (0.34%)
NSE Apr 17, 2025 15:31 PM
Volume: 19,592
 

1774.90
0.34%

Hester Biosciences Ltd 1QFY17 result update

BOB Capital Markets Ltd.
Hester Biosciences Ltd. posted robust growth in 1QFY17 with revenue growth of 22.8%/6.9% YoY/QoQ, respectively, to Rs 301mn led by 21.6%/41% growth in poultry segment/Large animal segment. EBITDA for the quarter grew by 31%/9.8% YoY/QoQ respectively to Rs 107mn with the expansion in EBITDA margins by 222/94bps YoY/QoQ to 35.5% mainly due to shift in product mix, better inventory management, credit control and lower financing cost.
Hester Biosciences Ltd. is trading above its 50 day SMA of 1592.1
More from Hester Biosciences Ltd.
Recommended